). Neurological abnormalities have occurred at levels of 350 mosmol/kg, and death at levels of 395 mosmol/kg in experiments on hypertonicity in rabbits (Sotos 1960) . Two children out of thirteen in our series developed rises of just under 10% in serum osmolality. Highest serum osmolality recorded was 317 mosmol/kg. No signs attributable to hyperosmolality were noted.
The increase in serum osmolality itself leads to another complication, rapid passage of extravascular water into the intravascular space, accompanied by marked changes in PCV and serum chloride. With changes in osmolality and PCV as we found, plasma volume changes of 50-100 ml could be expected.
Such expansion of plasma volume could be disastrous in infants already in heart failure, and marked deterioration did occur in 4 out of 5 such infants.
Raised serum osmolality and increased plasma volume will take longer to return to normal because of delayed excretion of contrast, renal function being impaired in infancy, cyanosis, and heart failure.
During cardiac catheterization cyanosed in- By chance, some babies with congenital abnormalities will be born each year to mothers who are being treated for epilepsy. However, after encountering six babies with cleft lip and palate who had epileptic mothers, the question arose whether factors other than chance might be operating. Of these six children, two had ventricular septal defects, and all had minor skull and facial abnormalities apart from the cleft lip and palate. Similar abnormalities have been reported following the unsuccessful abortifacient use of aminopterin and methotrexate in early pregnancy (Milunsky et al. 1968 ). These two drugs are folic acid antagonists, and it is recognized that anticonvulsant drugs seem to act as if antagonizing folic acid in many patients, for instance in producing folic acid deficiency anemia. Whether this action of anticonvulsants might harm the human foetus is not known.
Therefore, a letter was written to the Lancet (Meadow 1968) asking for the details of babies with cleft lip and palate who had been born to mothers receiving anticonvulsant therapy.
Results
From the replies a list of 32 children with cleft lip and/or palate was compiled. Thirty-one had cleft lip and/or palate, only one had isolated cleft palate.
Their mothers had epilepsy, and about a quarter were known to have had a fit during the first three months of pregnancy. All the mothers took substantial doses ofanticonvulsants throughout pregnancy, and all but two took a combination of two or more drugs. The drugs taken are shown in Table 1 , and are much as would be anticipated. No single drug appears in an unexpected position in that table.
Seven families had two similarly affected children; there were four pairs of siblings, two pairs of monozygotic twins, and one pair of dizygotic twins. Eleven of the 32 children had other major congenital abnormalities. Eight had a congenital heart lesion, which in seven was a ventricular septal defect. Four of these children had developed infundibular stenosis which had led to reversal of the intracardiac shunt and cyanosis.
Eleven had marked facial abnormalities. It is difficult to define the additional abnormalities of a face already marred by a cleft lip. Nevertheless, the doctors concerned considered there were abnormalities in addition to those associated with the cleft. There were two or more of the following: skull bone defects and trigonocephaly, short neck with low posterior hair line, broad nose root and hypertelorism, prominent eyes and low-set ears with deformities of the pinna. Because of the facial abnormalities, some had been transferred to special units for chromosome investigation, Patau's syndrome being suspected. The chromosome studies were normal.
Six of the children were known to have minor peripheral skeletal abnormalities.
Full details of all siblings were not available, but there were five siblings reported who had a major congenital abnormality with a normal lip and palate. Four had ventricular septal defects.
Discussion
Of the 32 cases reported, 20 children with cleft lip and/or palate were born in the five-year period 1964-68. One can estimate how many of these babies would be expected to be born to epileptic mothers by chance. Each year 850,000 mothers come to term in Britain. The number with epilepsy requiring substantial doses of anticonvulsants continuously is not known, but it is most unlikely to be more than 1 in 400. On that assumption 2,100 such mothers are delivered of babies each year. As the incidence of cleft lip and/ or palate in Britain is 1-2 per 1000, 2 5 babies with that defect would be expected to be born to them each year.
For the last five years my list shows an average of 4 cases every year. The actual figure is certainly more, as my list was compiled merely from replies to a letter in a medical journal. It must be incomplete and is known to be so, for other cases have been notified to the Committee on Safety of Drugs. Therefore, unless the number of epileptic mothers on substantial doses of anticonvulsant drugs is much greater than is thought, there have been born to those mothers in the last five years more children with cleft lip and palate than expected.
Other aspects of the cases reported are also suggestive. There is an apparently high incidence of congenital heart disease (25 %) compared with the 3-5 % found in other series of children with cleft lip and/or palate (Drillien et al. 1966) . There is also an apparently high incidence of both cleft lip and/or palate and other congenital abnormalities in the siblings. These facts cannot be critically examined because of the way in which the information was collected. It may be that appeals to a correspondence column result in the most severe and multiple abnormalities being preferentially reported. As it is there is certainly a suggestion that several of the children had a syndrome of abnormalities involving the lip and palate, cardiovascular and skeletal systems. All these facts prove nothing. They are merely suggestive, but the suggestion is sufficiently provocative to demand large scale investigation. The first step is to find out if there really is an increased incidence of cleft lip and/or palate in babies born to epileptic mothers. One small survey (Janz & Fuchs 1964) of 262 epileptic mothers receiving treatment reported three children with cleft lip and/or palate. If an increased incidence is found, the next step is to try to find if it is linked with the maternal disease or the drugs.
Anticonvulsant drugs cross the placenta well.
Melchior et al. (1967) found phenobarbitone levels in the human umbilical cord to be 95 % that of the maternal serum. This work was done on 32 pregnant mothers, and it is noteworthy that they produced two babies with cleft lip and/or palate. Genetic factors are known to play a part in the etiology of cleft lip and/or palate; there is a positive family history in just over a third of cases (Fogh Anderson 1968). Any exogenous factors must act by the eighth week of feetal life when the lip and palate are closed. It is during these early weeks that aminopterin and other folic acid antagonists have been shown to cause cleft lip and/or palate. Animal experiments are needed to find out if anticonvulsants predispose towards clefts in animals and if so whether the addition of folic acid prevents it.
It is important not to exaggerate the hypothesis that has been put forward. There is no proof; the information is merely suggestive. Anticonvulsant drugs are of immense value to the community and even if it were shown that anticonvulsant drugs were associated with an increased incidence of certain congenital abnormalities, it is likely that for the individual epileptic mother it would still be a small chance of such abnormality.
